These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

185 related articles for article (PubMed ID: 36294824)

  • 21. Cuproptosis-related gene
    Wang T; Liu Y; Li Q; Luo Y; Liu D; Li B
    Front Immunol; 2022; 13():999823. PubMed ID: 36225932
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Prognostic Immunophenotyping Clusters of Clear Cell Renal Cell Carcinoma Defined by the Unique Tumor Immune Microenvironment.
    Xu W; Anwaier A; Ma C; Liu W; Tian X; Su J; Zhu W; Shi G; Wei S; Xu H; Qu Y; Ye D; Zhang H
    Front Cell Dev Biol; 2021; 9():785410. PubMed ID: 34938737
    [No Abstract]   [Full Text] [Related]  

  • 23. Integrated multi-omics analyses reveal that BCAM is associated with epigenetic modification and tumor microenvironment subtypes of clear cell renal cell carcinoma.
    Zhao J; Liang J; Yang Y; Sun G; Zhang X; Zhao J; Hu X; Chen J; Zhu S; Ni Y; Zhang Y; Dai J; Wang Z; Wang Z; Zeng Y; Yao J; Chen N; Shen P; Liu Z; Zeng H
    Clin Epigenetics; 2022 Aug; 14(1):99. PubMed ID: 35941663
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Development of an Immune Prognostic Model for Clear Cell Renal Cell Carcinoma Based on Tumor Microenvironment.
    Wang M; Song Q; Song Z; Xie Y
    Horm Metab Res; 2023 Jun; 55(6):402-412. PubMed ID: 37192644
    [TBL] [Abstract][Full Text] [Related]  

  • 25. FCER1G positively relates to macrophage infiltration in clear cell renal cell carcinoma and contributes to unfavorable prognosis by regulating tumor immunity.
    Dong K; Chen W; Pan X; Wang H; Sun Y; Qian C; Chen W; Wang C; Yang F; Cui X
    BMC Cancer; 2022 Feb; 22(1):140. PubMed ID: 35120484
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Comprehensive analysis of 7-methylguanosine and immune microenvironment characteristics in clear cell renal cell carcinomas.
    Xiao Y; Yang J; Yang M; Len J; Yu Y
    Front Genet; 2022; 13():866819. PubMed ID: 36003341
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Integrative Analysis of the Genomic and Immune Microenvironment Characteristics Associated With Clear Cell Renal Cell Carcinoma Progression: Implications for Prognosis and Immunotherapy.
    Lin E; Zhu P; Ye C; Huang M; Liu X; Tian K; Tang Y; Zeng J; Cheng S; Liu J; Liu Y; Yu Y
    Front Immunol; 2022; 13():830220. PubMed ID: 35677048
    [TBL] [Abstract][Full Text] [Related]  

  • 28. POLD1 as a Prognostic Biomarker Correlated with Cell Proliferation and Immune Infiltration in Clear Cell Renal Cell Carcinoma.
    Tian J; Cheng C; Gao J; Fu G; Xu Z; Chen X; Wu Y; Jin B
    Int J Mol Sci; 2023 Apr; 24(7):. PubMed ID: 37047824
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A Novel Lymphangiogenesis-Related Gene Signature can Predict Prognosis and Immunosuppressive Microenvironment in Patients with Clear Cell Renal Cell Carcinoma.
    Chen K; Gao M; Dong W; Liu H; Lin Y; Xie Y; Zhong W; Chen J; Huang X; He W; Lin T; Wang B; Huang J
    Int J Med Sci; 2023; 20(6):754-770. PubMed ID: 37213667
    [No Abstract]   [Full Text] [Related]  

  • 30. A Ferroptosis-Related Genes Model Allows for Prognosis and Treatment Stratification of Clear Cell Renal Cell Carcinoma: A Bioinformatics Analysis and Experimental Verification.
    Wu J; Sun Z; Bi Q; Wang W
    Front Oncol; 2022; 12():815223. PubMed ID: 35155251
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Global Characterization of Immune Infiltration in Clear Cell Renal Cell Carcinoma.
    Zheng Y; Wen Y; Cao H; Gu Y; Yan L; Wang Y; Wang L; Zhang L; Shao F
    Onco Targets Ther; 2021; 14():2085-2100. PubMed ID: 33790572
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Coordinated reprogramming of renal cancer transcriptome, metabolome and secretome associates with immune tumor infiltration.
    Poplawski P; Alseekh S; Jankowska U; Skupien-Rabian B; Iwanicka-Nowicka R; Kossowska H; Fogtman A; Rybicka B; Bogusławska J; Adamiok-Ostrowska A; Hanusek K; Hanusek J; Koblowska M; Fernie AR; Piekiełko-Witkowska A
    Cancer Cell Int; 2023 Jan; 23(1):2. PubMed ID: 36604669
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The levels of IL-6 and soluble IL-33R are increased in the renal vein during surgery for clear cell renal cell carcinoma.
    Gudbrandsdottir G; Aarstad HH; Hjelle KM; Førde K; Reisæter L; Bostad L; Aarstad HJ; Beisland C
    Cytokine; 2021 Aug; 144():155586. PubMed ID: 34058568
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Integrated analysis of immune-related gene subtype and immune index for immunotherapy in clear cell renal cell carcinoma.
    Bai D; Chen S; Feng H; Yin A; Lu J; Ma Y; Sugiyama H
    Pathol Res Pract; 2021 Sep; 225():153557. PubMed ID: 34329838
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Endosialin-positive tumor-derived pericytes promote tumor progression through impeding the infiltration of CD8
    Lu T; Zhang J; Lu S; Yang F; Gan L; Wu X; Song H; Liu S; Xu C; Han D; Yang B; Wen W; Qin W; Yang L
    Cancer Immunol Immunother; 2023 Jun; 72(6):1739-1750. PubMed ID: 36646951
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Fatty acids metabolism affects the therapeutic effect of anti-PD-1/PD-L1 in tumor immune microenvironment in clear cell renal cell carcinoma.
    Lin H; Fu L; Li P; Zhu J; Xu Q; Wang Y; Mumin MA; Zhou X; Chen Y; Shu G; Yao G; Chen M; Lu J; Zhang L; Liu Y; Zhao Y; Bao J; Chen W; Luo J; Li X; Chen Z; Cao J
    J Transl Med; 2023 May; 21(1):343. PubMed ID: 37221577
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Identification of Immune-Related Cells and Genes in Tumor Microenvironment of Clear Cell Renal Cell Carcinoma.
    Du B; Zhou Y; Yi X; Zhao T; Tang C; Shen T; Zhou K; Wei H; Xu S; Dong J; Qu L; He H; Zhou W
    Front Oncol; 2020; 10():1770. PubMed ID: 33014871
    [TBL] [Abstract][Full Text] [Related]  

  • 38. LAGE3 correlates with tumorigenic immune infiltrates in the clear cell renal cell carcinoma microenvironment.
    Dong X; Gu DN; Wang O; Ye Z
    Int Immunopharmacol; 2020 Oct; 87():106793. PubMed ID: 32683301
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Analysis of Pyroptosis-Related Immune Signatures and Identification of Pyroptosis-Related LncRNA Prognostic Signature in Clear Cell Renal Cell Carcinoma.
    Zhong M; Wang X; Zhu E; Gong L; Fei L; Zhao L; Wu K; Tang C; Zhang L; Wang Z; Zheng Z
    Front Genet; 2022; 13():905051. PubMed ID: 35846134
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Identification and validation of novel prognostic markers in Renal Cell Carcinoma.
    Rabjerg M
    Dan Med J; 2017 Oct; 64(10):. PubMed ID: 28975890
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.